Phaos Technology Holdings Cayman Ltd Class A Ordinary Shares POAS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.17
- Day Range
- $0.16–0.17
- 52-Week Range
- $0.15–7.40
- Bid/Ask
- $0.15 / $0.19
- Shares Outstanding
- 16.45M
- Market Cap
- $2.71M
- Volume/Avg
- 861,876 / 346,650
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 20.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers high tech microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 10
- Website
- https://www.phaostech.com
Valuation
|
Metric
|
POAS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.65 |
Price/Sales | 20.20 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
POAS
|
|---|---|
Quick Ratio | 0.61 |
Current Ratio | 5.11 |
Interest Coverage | −670.76 |
Quick Ratio
POAS
Profitability
|
Metric
|
POAS
|
|---|---|
Return on Assets (Normalized) | −189.28% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −2,528.19% |
Return on Assets
POAS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|t$%FTX | LOCK|#G%! | $187B | |||
| Medtronic PLC
MDT
| LOCK|gL#L$& | LOCK|x><Y | $120B | |||
| Stryker Corp
SYK
| LOCK|Fh@VdH## | LOCK|VgW | $116B | |||
| Boston Scientific Corp
BSX
| LOCK|JtyNXy | LOCK|Z>YlY | $69B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!^#x&%>s | LOCK|#f$< | $52B | |||
| DexCom Inc
DXCM
| LOCK|gr@#&C! | LOCK|Q@?NQ | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|k?P!^DN | LOCK|Qr | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|>! | LOCK|JQ | $25B | |||
| Steris PLC
STE
| LOCK|rQ>Q?&F | LOCK|btLk! | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|<%%D<XZ | LOCK|bm | $19B |
United States